January 2021 Papers | All 2020 Published Papers by Month
February 26, 2021
- Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup – NEJM
- Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020 – CDC
- Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells – BMJ
- SARS-CoV-2 Respiratory Co-Infections: Incidence of Viral and Bacterial Co-Pathogens – International Journal of Infectious Diseases
February 25, 2021
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting – NEJM
February 24, 2021
- Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19 – Frontiers in Immunology
February 23, 2021
February 19, 2021
- Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants – Nature
February 18, 2021
- Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19 – Lancet
- Challenges in interpreting SARS-CoV-2 serological results in African countries – Lancet
February 12, 2021
- Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey – Lancet
February 10, 2021
- Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia – Nature
February 5, 2021
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial – Lancet
- Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines – JAMA
- SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas – Nature
- Imaging of SARS-CoV-2 infected Vero E6 cells by helium ion microscopy – Journal of Nanotechnology
February 4, 2021
- Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 – NEJM
- Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine – The Lancet (preprint)
- Bioaerosol sampling for SARS-CoV-2 in a referral center with critically ill COVID-19 patients March-May 2020 – Clinical Infectious Diseases
February 3, 2021
- Exaggerated risk of transmission of COVID-19 by fomites – The Lancet
- SARS-CoV-2 infection rate very high amongst UK strictly-Orthodox Jewish community – London School of Hygiene and Tropical Medicine
February 2, 2021
- Viral Loads of SARS-CoV-2 in Young Children – JAMA
- Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios – JAMA Pediatrics
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine – JAMA